OmniBRx Biotechnologies
PrivateLast Round
Series A
Mar 13, 2023
Total Funding Raised
$3.71M
Company Overview
OmniBRx Biotechnologies operates in Healthcare & Life Sciences and is based in Ahmedabad, Gujarat. Its latest recorded funding round was a Series A round in March 2023.
OmniBRx Biotechnologies is a biotechnology company that provides upstream bioprocessing solutions, including the design, development, and manufacturing of single-use bioreactor platforms for cell culture applications such as vaccines, viral vectors, and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OmniBRx Biotechnologies Comparables
Compare OmniBRx Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PBS Biotech | 80% | |
| Donaldson Company | 79% | |
| Esco Lifesciences Group | 78% |
For institutional investors. Book with your work email.
OmniBRx Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 13, 2023 | ||||
| Grant | May 15, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OmniBRx Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Seed, Grant |
| Venture Center | Seed |
| SIDBI Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2025
Monthly visitors increased 48% MoM.
- Jan 15, 2025
Monthly visitors increased 389% MoM.
For institutional investors. Book with your work email.
OmniBRx Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OmniBRx Biotechnologies's valuation, stock price, and market status.
Is OmniBRx Biotechnologies a public or private company?
OmniBRx Biotechnologies is a private company.
What is the current stock price of OmniBRx Biotechnologies?
OmniBRx Biotechnologies is a private company, so its shares have no public market price. Caplight tracks OmniBRx Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OmniBRx Biotechnologies worth (valuation)?
Valuation information for OmniBRx Biotechnologies is not publicly available.
Can I buy OmniBRx Biotechnologies stock?
OmniBRx Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OmniBRx Biotechnologies's last funding round?
OmniBRx Biotechnologies's most recent funding round was Series A on March 13, 2023.
Who are the main investors in OmniBRx Biotechnologies?
Key investors in OmniBRx Biotechnologies include SIDBI Venture Capital.
Will OmniBRx Biotechnologies IPO soon?
No public IPO plans have been announced for OmniBRx Biotechnologies.
How can I track OmniBRx Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in OmniBRx Biotechnologies's shares on secondary markets.